Behavioral phenotype in the 9q subtelomeric deletion syndrome: A report about two adult patients

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 2, 2010, Pages 536-541

  Verhoeven, Willem M A ^a,b   Kleefstra, Tjitske ^c   Egger, Jos I M ^a,d  

^a VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

9qSTDS; Apathy; Behavioral phenotype; Mental retardation; Sleep disturbances

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; PHENOBARBITAL; PIPAMPERONE; PSYCHOTROPIC AGENT; VALPROIC ACID;

9Q SUBTELOMERIC DELETION SYNDROME; ADULT; APATHY; ARM; AROUSAL; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; CASE REPORT; CHROMOSOME DELETION; COMPLEX PARTIAL SEIZURE; DAYTIME SOMNOLENCE; DROWSINESS; DRUG DOSE INCREASE; FEMALE; FINGER; GENETICS; HUMAN; MALE; MOOD DISORDER; NEUROPSYCHIATRY; PHENOTYPE; PRIORITY JOURNAL; SLEEP DISORDER; SLEEP PATTERN; STEREOTYPY; TONIC CLONIC SEIZURE;

BEHAVIOR; BONE AND BONES; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; MODELS, GENETIC; MUSCLE HYPOTONIA; NETHERLANDS; PHENOTYPE; SYNDROME; TELOMERE;

EID: 77349086396     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31015     Document Type: Article

References (29)

1. Bush G, Fink M, Petrides G, Dowling F, Francis A. 1996. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand 93:129-136.
2. Cormier-Daire V, Molinari F, Rio M, Raoul O, de Blois MC, Romana S, Vekemans M, Munnich A, Colleaux L. 2003. Cryptic terminal deletion of chromosome 9q34: A novel cause of syndromic obesity in childhood. J Med Genet 40:300-303.
3. Dawson AJ, Putnam S, Schultz J, Riordan D, Prasad C, Greenberg CR, Chodirker BN, Mhanni AA, Chudley AE. 2002. Cryptic chromosome rearrangements detected by subtelomere assay in patients with mental retardation and dysmorphic features. Clin Genet 62:488-494.
4. De Leersnyder H. 2006. Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: From symptoms to treatment. Trends Endrocrinol Metab 17:291-298.
5. 1-Adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome. J Med Genet 40:74-78.
6. Fink M, Taylor MA, Ghaziuddin N. 2006. Catatonia in autistic spectrum disorders: A medical treatment algorithm. Int Rev Neurobiol 72:233-244.
7. Gropman AL, Elsea S, Duncan WC, Smith ACM. 2007. New developments in Smith-Magenis syndrome (del 17p11.2). Curr Opin Neurol 20:125-134.
8. Hardy SE. 2009. Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults. Am J Geriatr Pharmacother 7:34-59.
9. Kleefstra T, Smidt M, Banning MJG, Oudakker AR, van Esch H, de Brouwer APM, Nillesen W, Sistermans EA, Hamel BCJ, de Bruijn D, et al. 2005. Disruption of the gene euchromatin histone methyl transferase 1 (Eu-HMTase 1) is associated with the 9q34 subtelomeric deletion syndrome. J Med Genet 42:299-306.
10. Kleefstra T, Brunner H, Amiel J, Oudakker AR, Nillesen WM, Magee A, Geneviève D, Cornier-Daine V, van Esch H, Fryns JP, Hamel BJC, et al. 2006a. Loss-of function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q24 subtelomeric deletion syndrome. Am J Hum Genet 79:370-377.
11. Kleefstra T, Koolen DA, Millesen WM, de Leeuw N, Hamel BCJ, Veltman JA, Sistermans EA, van Bokhoven H, van Ravenswaay C, de Vries BBA. 2006b. Interstitial 2.2. Mb deletion at 9q34 in a patient with mental retardation but without classical features of the 9q subtelomeric deletion syndrome. Am J Med Genet Part A 140A:618-623.
12. Kleefstra T, van Zelst-Stams WA, Nillesen WM, Cormier-Daire V, Houge G, Foulds N, van Dooren M, Willemsen MH, Pfundt R, Turner A, et al. 2009. Further clinical and molecular delineations of the 9q subtelomeric deletion syndrome support a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet Mar 4 [Epub ahead].
13. Levy R, Czernecki V. 2006. Apathy and the basal ganglia. J Neurol 253-(Suppl 7): 54-61.
14. Levy R, Dubois B. 2006. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 16:916-928.
15. Marin RS. 1990. Differential diagnosis and classification of apathy. Am J Psychiatry 147:22-30.
16. Marin RS. 1991. Apathy: A neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3:243-254.
17. Marin RS. 1996. Apathy: Concept, syndrome, neural mechanisms and treatment. Semin Clin Neuropsychiatry 1:304-314.
18. Marin RS, Biedrzycki RC, Firinciogullari S. 1991. Reliability and validity of the apathy evaluation scale. Psychiatry Res 38:143-162.
19. Matson JL, Kazdin AE, Senatore V. 1984. Psychometric properties of the psychopathological instrument for mentally retarded adults. Appl Res Ment Retard 5:81-89.
20. Ravlan JB, Tepperberg JH, Papenhausen P, Lamb AN, Hedrick J, Eash D, Ledbetter DH, Martin CL. 2006. Subtelomere FISH analysis of 11688 cases: An evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities. J Med Genet 43:478-489.
21. Seethalakshmi R, Dhavale S, Suggu K, Dewan M. 2008. Catatonic syndrome: Importance of detection and treatment with lorazepam. Ann Clin Psychiatry 20:5-8.
22. Smith ACM, Dykens E, Greenberg F. 1998. Sleep disturbance in Smith-Magenis syndrome (del17p11.2). Am J Med Genet 81:186-191.
23. Starkstein SE, Leentjes AFG. 2008. The nosological position of apathy in clinical practice. J Neurol Neurosurg Psychiatry 79:1088-1092.
24. Stewart DR, Kleefstra T. 2007. The chromosome 9q subtelomere deletion syndrome. Am J Med Genet Part C 145C:383-392.
25. Stewart DR, Huang A, Faravelli F, Anderlid BM, Medne L, Ciprero K, Kaur M, Rossi E, Tenconi R, Nordenskjöld M, et al. 2004. Subtelomeric deletions of chromosome 9q: A novel microdeletion syndrome. Am J Med Genet Part A 128A:340-351.
26. Verhoeven WMA, Tuinier S, van der Burgt I. 2008. Top-down or bottom-up: Contrasting perspectives on psychiatric diagnoses. Biol Targets Ther 2:409-417.
27. Wheeler B, Taylor B, Simonsen K, Reith DM. 2005. Melatonin treatment in Smith Magenis syndrome. Sleep 28:1609-1610.
28. Yatsenko SA, Cheung SW, Scott DA, Nowaczyk MJ, Tarnopolsky M, Naidu S, Bibat G, Patel A, Leroy JG, Scaglia F, et al. 2005. Deletion 9q34.3 syndrome: Genotype-phenotype correlations and an extended deletion in a patient with features of Opitz C trigonocephaly. J Med Genet 42:328-335.
29. Yatsenko SA, Brundage EK, Roney EK, Cheung SW, Chinault AC, Lupski JR. 2009. Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3 microdeletion syndrome. Hum Mol Genet 18:1924-1936.